< back to search

Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

Davis, John C Jr   •   van der Heijde, Desiree   •   Braun, Jurgen   •   Dougados, Maxime   •   Cush, John   •   Clegg, Daniel O   •   Kivitz, Alan   •   Fleischmann, Roy   •   Inman, Robert   •   Tsuji, Wayne

published in: Arthritis and rheumatism



endpoint

Etanercept has (optional: compared with placebo) proved to be better.
general condition better


basics

diagnosis:
ankylosing spondylitis

localization:
not specified

method:
conservative therapy → injection therapy
conservative therapy → injection

publication details

10.1002/art.11325
pubmed
14613288
2003
randomized controlled trial
yes
prospective
1+

▼
▲